SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,766 | -19,742 | -85,148 | -66,303 | -31,198 |
| Depreciation Amortization | 127 | 63 | 20 | 16 | 103 |
| Accounts receivable | -7,688 | -2,132 | -7,289 | -4,728 | -1,627 |
| Accounts payable and accrued liabilities | 5,101 | 1,388 | 592 | 2,018 | -302 |
| Other Working Capital | -2,722 | -224 | -13,092 | -13,256 | -8,943 |
| Other Operating Activity | 9,698 | 3,508 | 34,379 | 26,901 | 4,039 |
| Operating Cash Flow | $-33,250 | $-17,139 | $-70,538 | $-55,352 | $-37,928 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 29,320 | 29,320 | 29,320 |
| PPE Investments | N/A | N/A | -21 | -9 | N/A |
| Investing Cash Flow | $N/A | $N/A | $29,299 | $29,311 | $29,320 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 46,772 | 46,772 | N/A |
| Debt Repayment | -1,912 | N/A | -50,000 | -50,000 | N/A |
| Common Stock Issued | 316 | N/A | 53,775 | 53,775 | 464 |
| Other Financing Activity | 0 | -972 | 19,533 | 20,164 | -166 |
| Financing Cash Flow | $-1,596 | $-972 | $70,080 | $70,711 | $298 |
| Beginning Cash Position | 75,655 | 75,655 | 46,814 | 46,814 | 46,814 |
| End Cash Position | 40,809 | 57,544 | 75,655 | 91,484 | 38,504 |
| Net Cash Flow | $-34,846 | $-18,111 | $28,841 | $44,670 | $-8,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,250 | -17,139 | -70,538 | -55,352 | -37,928 |
| Capital Expenditure | N/A | N/A | -21 | -9 | N/A |
| Free Cash Flow | -33,250 | -17,139 | -70,559 | -55,361 | -37,928 |